1. Home
  2. AQST vs TECX Comparison

AQST vs TECX Comparison

Compare AQST & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.21

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.33

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQST
TECX
Founded
2004
2019
Country
United States
United States
Employees
N/A
60
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.0M
545.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AQST
TECX
Price
$4.21
$30.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$9.00
$75.25
AVG Volume (30 Days)
1.4M
169.6K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,430,000.00
N/A
Revenue This Year
$10.08
N/A
Revenue Next Year
$49.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.77
N/A
52 Week Low
$2.22
$14.39
52 Week High
$7.55
$35.99

Technical Indicators

Market Signals
Indicator
AQST
TECX
Relative Strength Index (RSI) 54.98 52.95
Support Level $3.70 $28.31
Resistance Level $4.42 $32.27
Average True Range (ATR) 0.15 1.53
MACD 0.01 -0.28
Stochastic Oscillator 76.90 48.05

Price Performance

Historical Comparison
AQST
TECX

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: